Léčebná studie Relapsed AML 2001/01, 02 pro děti s relapsem akutní myeloidní leukemie nebo primárně rezistentní nemocí zlepšila jejich nadeji na vyléčení.

• Title in English: The Relapsed AML 2001/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome
• Authors: ZDRÁHALOVÁ K.; SEDLÁČEK P.; SMÍŠEK P.; KESLOVÁ P.; ŠTĚRBA Jaroslav; HRSTKOVÁ Hana; BLAŽEK B.; MIHÁL V.; HAK J.; PROCHÁZKOVÁ D.; ČERNÁ Z.; TIMR P.; ZEMANOVÁ Z.; JAROŠOVÁ M.; OLTOVÁ Alexandra; SCHWARZ J.; POSPÍŠILOVÁ Šárka; MEJSTŘÍKOVÁ Ester; HRUŠÁK O.; ZUNA J.; VODIČKOVÁ E.; ZÁMKOVÁ A.; BLATNÝ J.; ZAPLETAL O.; VÁVRA V.; JANOTOVÁ I.; STARÝ J.
• Year of publication: 2011
• Type: Article in Periodical
• Magazine / Source: Transfuze a hematologie dnes
• MU Faculty or unit: Central European Institute of Technology
• Field: Oncology and hematology
• Keywords: acute myeloid leukemia; relapse; resistance; Relapsed AML 2001; children
• Description: Relapse of acute myeloid leukaemia (AML) or AML initially resistant to treatment is extremely prognostically unfavourable. Between VIII/2001 and III/2009 in the Czech Republic, twenty patients aged 0-18 years with diagnosis were treated as part of the international Relapsed AML 2001/01 study.

Related projects

• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies